Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2440${count})

  • Alpha-Synuclein Biology, 2018
    Using Powerful Metabolomic Methods to Identify Blood-based Biomarkers of Early-Stage Parkinson's Disease

    Study Rationale:
    Metabolomics is an approach to studying molecules that are products of metabolism. Using metabolomics, we identified a unique feature -- metabolic fingerprint -- in the blood of pre...

  • Research Grant, 2018
    A Global Database of People with Inherited Parkinson's Disease

    Study Rationale:
    Changes (mutations) in genes PRKN, PINK1, DJ1, SNCA, LRRK2 and VPS35 can cause inherited Parkinson's disease (PD). Also, mutations in the GBA gene are associated with an increased...

  • Access to Data and Biospecimens, 2018
    Studying Methylation in the PPMI Cohort to Develop New Biomarkers

    Study Rationale:
    Because Parkinson's disease (PD) is a complex disease, it is difficult to accurately diagnose and treat. Biomarkers -- disease indicators that are critical missing links in the search...

  • Research Grant, 2018
    Allosteric Targeting of LRRK2 Using Stapled Peptides

    Study Rationale:
    Mutations in the LRRK2 gene -- which alter enzymatic activity in the LRRK2 protein -- are associated with increased risk of Parkinson's disease. The protein is known to aggregate into...

  • Target Advancement Program, 2018
    Role of 5-alpha Reductase 1 in the Therapy of Neurodegeneration and Levodopa-induced Dyskinesias

    Study Rationale:
    The two main types of the enzyme 5α-reductase (5αR) play a key role in the production of steroids in the brain and other organs. In pre-clinical testing, we found that inhibitors of...

  • Access to Data & Biospecimens, 2018
    Rapid and Ultra-sensitive Quantitation of Disease-associated and Synuclein Seeds in Brain and Cerebrospinal Fluid by Syn RT-QuIC

    Study Rationale:                   

    The diagnosis and treatment of Parkinson’s disease (PD) would be aided by the availability of direct and highly sensitive tests for the abnormal clusters of the...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.